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Abstract:
Every year, in the United States, between 100-200 babies are infected prenatally with
HIV. With the use of antiretroviral medications, elective cesarean section and
formula feeding, the risk of vertical transmission can be reduced to less than 2%. In
this paper I analyzed whether or not state governments should mandate HIV testing
for all pregnant women in order to reduce vertical transmission of HIV. By looking at
the cases for and against mandatory testing, as well as looking at states such as
Connecticut who have implemented mandatory testing, I will present the case for
why the benefit of mandatory testing outweighs the potential harm that could be
inflicted as a result.
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Introduction
Today in America one of the largest social issues that we struggle with is
distinguishing whose rights should ethically, morally and legally come first-that of the woman or that of the fetus. While most people only think of this
argument in the terms of abortion rights, in this paper I will be looking at the
issue from the standpoint of preventing the vertical transmission of HIV.
According to the Centers for Disease Control and Prevention (CDC), as of
2007 AIDS has been diagnosed for an estimated 8,460 children who were
infected perinatally. Of those, an estimated 4,800 have died and every year
between 100 and 200 children are infected with HIV. Of these cases 91% are
due to perinatal transmission (CDC 2007). One third of babies born with HIV
will die after one year if they do not receive any form of antiretroviral
treatment. After the second year of life, almost 50% of infants not receiving
treatment will die (World Heath Organization, 2006). With numbers like
these, it is imperative that we not only treat infants with HIV as soon as
possible, but also that we prevent the transmission of HIV in the first place.
In 1994, the AIDS Clinical Trials Group (ACTG) released a
breakthrough study, protocol 076, which showed that the use of zidovudine
started after the first trimester, continuing during childbirth and administered
to infants for six weeks post-partum could substantially reduce the vertical
transmission of HIV from HIV positive mothers to their newborn children
(CDC 1994). Prior to the implementation of protocol 076 in the United States
when HIV positive women who were pregnant did not receive any form of
antiretroviral treatment during pregnancy or labor, newborns of HIV positive
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mothers had a 25% chance of acquiring HIV infection (CDC 1994). Since the
adoption of the prophylactic protocol for HIV positive pregnant women, along
with increased cesarean sections and increased testing of HIV during
pregnancy, the risk of mother-to-child transmission has been reduced to less
than 2% in the United States (Simpson & Forsyth 2007). For an infant whose
antiretroviral therapy began while in utero, but no other precautions were
taken, the risk of HIV transmission in 8.3% (CDC 1994). This breakthrough
gave HIV positive women the choice to become pregnant knowing that such
treatment could greatly decrease their infants’ risk of potential HIV infection.
Yet one of the biggest barriers to the near elimination of mother-tochild transmission of HIV is that screening and prophylactic treatment is not
always implemented. A key reason for this lack of implementation of such life
saving treatment is that HIV testing of pregnant women is not universal.
Before the 2006 revision by the Center for Disease Control and Prevention of
its recommendation regarding HIV testing during pregnancy, the standard of
care was for health care providers to counsel pregnant women and offer
women an HIV test with the women’s written informed consent (Schuklenk &
Kleinsmidt 2007). This method is known as opt-in testing. Opt-in testing
included target testing, in which health care providers would offer an HIV test
only to women who they saw as ‘at risk’ for HIV. Since it is the physician’s
decision whether to offer an HIV test, opt-in and target testing are weak
preventive measures in which women who do not fit the HIV ‘profile’ fall
through the cracks. The current recommendation from the CDC now states,
“All pregnant women in the United States should be screened for HIV
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infection. Screening should occur after a women is notified that HIV
screening is recommended for all pregnant patients and that she will receive
an HIV test as part of the routine panel of prenatal tests unless she declines
(opt-out screening)” (Branson, 2006). By making HIV testing part of routine
prenatal testing, the CDC sought to “normalize” HIV testing and take away
some of the stigma associated with getting tested for HIV. The overall goal of
this new recommendation was to increase the number of women who would
get tested during pregnancy in the hope that the number of newborns each
year who acquire HIV infection as a result of mother-to-child transmission
would be greatly reduced.
Even with opt-out testing, some HIV positive women refuse to take the
test. This has prompted some states, such as New York and Connecticut to
institute mandatory HIV testing of infants at the time of birth in order to start
antiretroviral therapy as soon as possible. There have been some concerns
expressed over such laws, stating that they are a roundabout way of testing the
mother. At the same time, ethicists and others have raised questions of
whether or not we should go even further than the CDC recommendations or
if we have already gone to far. One such question is whether or not state
governments should make HIV testing during pregnancy mandatory. But what
are the ramifications of such a law and what legal precedent would the states
be able to use in supporting their decision? It is questions such as these that I
will be focusing on in this paper in order to find a middle ground that will
stand up against the contentions of people on the extreme end of the spectrum,
the law and ethics.
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In order to address the issues and questions above I will be reviewing
the arguments for and against mandatory testing during pregnancy. I will also
consider the impact that the abortion debate in America has on HIV testing.
Finally, I will be looking at other cases and precedents for mandatory testing
such as Connecticut Public Act 99-2 and routine syphilis testing during
prenatal visits.

Arguments Against Mandatory HIV Testing
Since the start of the AIDS epidemic, activists have held the gold
standard that the only acceptable type of HIV testing is voluntary and
confidential. It is important to note the difference between confidential testing
and anonymous testing. When a person is tested anonymously, no information
that can be linked to that person, such as name, address or phone number, is
recorded, and only that person keeps the results of their test. In contrast,
confidential testing keeps a record of each individual’s results, their
demographic information and how to contact them. Early in the HIV/AIDS
epidemic such protections as confidential testing were put into place for two
reasons. The first reason for this policy is that early on there was no adequate
treatment for HIV that could delay the onset of AIDS. Protections such as
these allowed for the choice of when and how to get tested for HIV in a time
when being HIV positive was a death sentence. Secondly, the stigma
associated with HIV was, and still is, great. If test results were not confidential
during the early years of the epidemic, HIV positive people could have
experienced even more significant discrimination.
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Concerns regarding stigma, discrimination and prejudice are the
rationale driving the argument against mandatory HIV testing during
pregnancy. “HIV/AIDS has characteristics that account for why it is so highly
stigmatized. First it is a disease that is perceived as the bearer’s responsibility
because the primary modes of transmission of the infection are behaviors that
are considered voluntary and avoidable and the subsequent perceptions of
people living with HIV/AIDS as people with no moral values” (Thomas et al,
2005, p. 795). These characteristics have created a social environment in
which “people identified as HIV-positive may be rejected by their families or
suffer discrimination in employment, access to health care, and housing if the
confidentiality of their test results is breached. Domestic violence against
HIV-infected women was identified as a particular risk.” (Lo et al, 2000, p.
S137) It is these potential results of having HIV that deter many women from
seeking out an HIV test in the first place. The potential of facing stigma,
discrimination and prejudice because of being HIV positive is still a very
likely possibility and one that plays a huge role in the spread of the epidemic
(Pisani, 2008).
Another ethical argument against making HIV testing mandatory is
autonomy. As of one the principles of bioethics (United States National
Commissions For The Protection Of Human Subjects Of Biomedical and
Behavioral Research, 1978), as well as an important value in American
culture, the right to autonomy is not something that can be easily overlooked.
Russell Armstrong, in his paper Mandatory HIV Testing In Pregnancy: Is
There Ever A Time? stated that “mandatory HIV testing in any situation is
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most problematic of any testing strategy… it involves very significant
limitation of individual autonomy and deep incursions into the domain if
individual privacy… In the absence of the ability to freely consent to an HIV
test, an individual loses the full power to determine under what circumstances
he or she chooses to learn this important life-altering fact” (Armstrong, 2008,
p. 3). He goes on further to say that this inability to choose in such a situation
could potentially instill distrust for the health care system.
It is this distrust that poses another potentially significant risk of
implementing mandatory HIV testing during pregnancy. As said by
Armstrong, “A woman who may already feel the most vulnerable in the
medical care environment, may feel even less respect or trust in a system that
refuses to let her be in charge of the decision of whether or not to have an HIV
test” (Armstrong, 2008, p. 3). This in turn could deter women from seeking
prenatal care in the first place by “making the receipt of prenatal care
contingent upon forced consent to and HIV test” (McMillion, 1998, p. 230).
This fear and distrust of mandatory testing could therefore have the potential
indirectly and unintentionally to cause even further harm. If women were
discouraged from seeking prenatal care due to being tested, they would not
benefit from prenatal health care that could prevent pre-mature labor or low
birth weight infants, a situation that would be counterproductive to the goals
that mandatory testing hopes to achieve.
Finally, a large concern of proponents against mandatory HIV testing
during pregnancy is how it would be enforced. If a woman declines to be
tested, is she subsequently able to receive care? Or would her prenatal care be
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dependant upon her cooperation and compliance with taking an HIV test? And
if the woman were found to be HIV positive, would she then be required to
receive prophylactic antiretroviral treatment? Or would she still have the
option to refuse such treatment? Since the main purpose of mandatory HIV
testing would be to start AZT treatment as early as possible, if women are
allowed to refuse treatment then would implementing a mandatory protocol
actually result in the increased acceptance of treatment? In a letter to the
editor of the American Journal of Public Health Alison K. Groves, MHS,
Matthew W. Pierce, JD, MPH, and Suzanne Maman, PhD, MHS said that
“knowing one’s HIV status does not necessarily lead women to engage in
treatment nor does it necessarily lead to change in risk behaviors” (Groves et
al, 2008, p. 196-197). The question is ultimately how far are the government
and health care providers willing to go in order to enforce such a law? Are
they willing to implement fines for refusing testing and treatment? Or are they
willing to go so far as to place pregnant women in the custody of the police in
order to achieve the maximum advantages that the policy has to offer? This
has been done before in the case of tuberculosis. Admittedly, the spread of
tuberculosis differs from vertical transmission of HIV. Tuberculosis has the
potential to spread via respiratory droplets in the air to others who may have
no connection to the person with active tuberculosis, whereas the vertical
transmission of HIV occurs within the most intimate contact of birth.
Nevertheless, in both cases a vulnerable person or persons could become
infected and prophylactic medication taken by the infected person can
potentially reduce such transmission.
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Arguments For Mandatory HIV Testing
It is hard to deny the science that compels people to consider
implementing mandatory HIV testing during pregnancy. Vertical transmission
rates since the application of protocol 076 have been dramatically reduced
when compared to the pre-protocol rates of the 1980’s and 1990’s. Numbers
such as these essentially speak for themselves. In addition to the prevention of
mother-to-child transmission of HIV is the fact that those protected by
prenatal and/or newborn HIV testing are infants, a population that in almost
every culture is seen as free of blame and one that should be protected from
harm at all costs. With all of the breakthroughs that have been made in the
prevention of vertical transmission, however, they would not be nearly as
effective if testing protocols did not diagnosis infected pregnant women
because women were not being tested. Without the knowledge of a woman’s
HIV status, health care providers would be unable to implement any of the
precautions that science has proven to reduce the risk of mother-to-child
transmission. Duo Schuklenk, PhD, and Anita Kliensmidt, LLB, LLM in their
paper Rethinking Mandatory HIV Testing During Pregnancy in Areas With
High HIV Prevalence Rates: Ethical and Policy Issues state “It is significant
that making it more difficult to avoid testing translates into larger numbers of
pregnant women finding out about their HIV state. In turn, they and their
health care providers are able to make informed choices about appropriate
courses of action” (Schuklenk & Kleinsmidt, 2007, p. 1179). It could be
argued that testing is the most important element in the fight against
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HIV/AIDS because testing not only allows people to become aware of their
status, but can also motivate people to reduce risky behaviors and begin
treatment.
By making HIV testing mandatory during pregnancy, a woman is able
to learn about her status earlier than she would if she never became pregnant.
This in turn allows her to begin antiretroviral therapy sooner, which benefits
not only her yet-to-be-born child but also herself. It is important to note that
“… the reasonable objective of any intervention must be to improve the health
of pregnant women and to prevent HIV transmission to newly born children,”
(Armstrong, 2008, p. 6) which mandatory testing has the ability to do if done
under the right circumstances. As for the health of the child, knowing a child’s
HIV status as soon as possible in order to start treatment is “particularly
important for children aged under 12 months as the probability of death in
untreated HIV-infected children is high: mortality rates of up to 40% by the
age of 1 year have been reported” (World Health Organization Department of
HIV/AIDS, 2006).
As stated earlier, the fear of stigma and discrimination are huge factors
for a woman when questioning whether or not she wants to ask for an HIV
test. Women are often afraid that their status will become public knowledge,
either because of a state or medical agency making it public or people
discovering it on their own. Yet in her book The Wisdom of Whores:
Bureaucrats, Brothels and Business of AIDS epidemiologist Elizabeth Pisani
argues the idea of people refusing an HIV test due to fear of stigma. Pisani
states that eventually an HIV positive person will begin to develop symptoms
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and eventually die, earlier than necessary. So she asks, what is worse?
Refusing an HIV test in order to avoid potential discrimination and in turn die
earlier because they were unable to receive treatment? Or taking an HIV test
and risking people discovering their status, yet still being able to start
treatment and living a longer and healthier life in which symptoms are kept at
bay (Pisani 2008)?
Although fear is a strong deterrent to getting tested, the potential to live a
longer and healthier life would seem to outweigh the fear of stigma. Getting
tested and subsequently receiving treatment, it could be argued, allows people
to live for a longer time without anyone else discovering their status. One
study suggests that fear of stigma is often much greater than experienced
stigma. “Thirty three percent of women and 20% of men experienced actual
stigma. However perceived stigma among women and men was 97% and 96%
respectively, disclosure concerns 85% and 86% and internalized stigma, 63%
and 62% respectively” (Thomas et al, 2005, p. 797).
What makes Pisani’s argument even more potent for pregnant women
is that in many cases the time frame that they are able to live without knowing
their HIV status is considerably shorter. Today, some states, such as New
York and Connecticut, have implemented mandatory HIV screening of
newborns in order to allow for the best chance to the infants to avoid HIV
transmission. Some people argue that newborn screenings have all of the same
ethical dilemmas as mandatory HIV testing during pregnancy, but seeing as at
the point of birth, the newborn is its own entity, it is easy to say that the
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newborn has the right to testing and treatment without interference from what
the mother feels is best for herself.
The United States is currently in an important transition between
treatment-based care and prevention-based care. In 2004 the United States
spent $1.9 trillion on health care. A majority of the spending went to treating
diseases such as diabetes, obesity, hypertension and chronic heart disease that
with the right type of care could have potentially been prevented (Agency for
Healthcare Research & Quality, 2006). HIV/AIDS is a preventable disease
that lasts a lifetime and comes with large associated costs. Treating HIV
includes continuous medications that are very costly as well as treatment for
any hospitalizations that occur due to opportunistic infections. According to a
study by Bruce R. Stickman, the monthly cost of HIV treatment (including
medications and hospitalizations) can range from $2,100 to $4,700 and the
annual cost for the United States on the whole could reach as high as $12.1
billion in the coming future (Shackman et al, 2006). Yet in comparison, the
prevention and testing of mother-to-child transmission of HIV is considerably
lower. It is “estimated that, compared with current practices, enhanced
prenatal screening would avert 150 infection in infants annually at a cost of
$8,900 per life-year gained. Routine HIV screening of newborns nationwide
would avert 266 infections in infants annually at a cost of $7,000 per life-year
gained. When enhanced prenatal screening is already in place, routine
screening of newborns would have a net cost of $10,600 per life-year
gained… Our analysis indicated that both newborn routine screening and
enhanced prenatal screening are cost effective” (Zaric et al, 2000, p. 410).
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Although this study did not specifically measure the cost effectiveness of
mandatory HIV testing during pregnancy, it is presumable that even stricter
protocols such as mandatory testing would provide even further health care
savings.
Finally, mandatory HIV testing has the potential to reduce stigma,
racial/ethnic and socioeconomic profiling as well as fear by making an HIV
test something that every woman does. This was the hope that the CDC has
for their revised recommendations that were published in 2006, but I believe
that mandatory testing could go even further. By making testing mandatory,
women who are not aware of themselves as being at risk of HIV would no
longer fall through the cracks that remain with opt-in and opt-out testing.
There is also a hope that by making HIV testing mandatory women who
would have been targeted would feel more comfortable getting tested knowing
that they were not being asked because they looked like a “stereotypical”
person with HIV/AIDS. The most important argument for mandatory testing
is that the United States has the potential to eradicate almost entirely the
perinatal transmission of HIV.

The Impact of the Abortion Debate on HIV Testing
The question of whether or not a state government has the legal and
ethical right to mandate HIV testing during pregnancy has many of the same
concerns as the abortion debate in America. The conflict is based on the
competing rights of the mother and the fetus. Following English Common
Law, legal personhood begins at birth. Rowe v. Wade, the historic Supreme
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Court decision allowing abortion was based on the right of the pregnant
woman to privacy taking precedence over the right of the fetus. Several
subsequent state-level laws instituted restrictions on pregnant women’s access
to abortion, once the fetus has developed to the point of “viability,” at about
23 weeks gestation (Tierney 2004). Viability, at about the fifth month of
pregnancy, means that the fetus could potentially survive outside of its
mother. Thus, once a fetus reaches the gestational age of viability, those state
laws granted it legal protection.
The conflict in regard to mandatory HIV testing during pregnancy
draws on such legal precedents in that it pits the mother’s right to autonomy
(and privacy) against the fetal right to be born without HIV infection. The
possibility of granting fetal rights is strongly opposed by those who fear that
such rights would be used to prohibit women’s access to abortion. But while a
fetus has few rights that are protected by law, a newborn certainly does. At the
time of birth, the time when a fetus becomes a newborn, rights are gained and
it is this small distinction that I argue in this paper.
Once a woman has made the decision to carry her baby to term,
without coercion and upon her own free will, she can be seen as taking on the
responsibility of protecting the rights of her not-yet-born child or newborn.
Since in most states abortion is no longer legally available past the gestational
age of fetal viability, after 23 weeks gestation it can be assumed that the
woman has made such a decision. This point is crucial to the argument for
mandatory HIV testing during pregnancy, as argued by Thomas H. Murray in
his book The Worth of a Child, “… parents of not-yet-born children, are
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obliged morally to act responsibly toward their charges, take reasonable steps
to advance their welfare, and avoid unnecessary risks of serious harm to
them.” (Murray, 1996, p. 102) Murray further argues that just as a woman has
the responsibility to stop smoking and drinking during a pregnancy in order to
prevent Fetal Alcohol Syndrome and other birth defects that could have been
prevented, a mother also has the responsibility to take all steps possible to
prevent her not-yet-born child from contracting a fatal disease such as HIV.
At the very least this should include an HIV test. Murray seeks to find a
“middle way” that acknowledges the rights and concerns of both the pregnant
women and her fetus. “A woman who becomes pregnant and that chooses to
carry that fetus to birth, does not become a moral hermit, stripped of all other
relationships, forbidden to consider even her own welfare except as it
concerns the fetus she carries. She remains a full-fledged moral agent, with a
complex variety of moral relationships, and with the right to consider her own
well-being” (Murray, 1996, p. 105). It is the hope that upon taking her own
well being into consideration, the woman would realize that taking an HIV
test and subsequently beginning anti-retroviral therapy she would be
improving not only the health of her not-yet-born child but also that of herself.

Connecticut Case Study
In October of 1999 Connecticut passed a law that mandated HIV
testing for the mother and if she refused a HIV test for the infant at the time of
birth. Five years after the implementation of this law, researchers B. Joyce
Simpson, ACRN, MPH and Brian W. Forsyth, MB ChB, FRCP(C) performed
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a study at Yale New Haven Hospital, in order to evaluate the personal
perspectives of the women who had discovered that they were HIV positive
during their pregnancy concerning Connecticut Public Act [CT P.A.] 99-2.
Between 1999 and 2005, 30 women (26.6% of all pregnant women tested at
the Yale New Haven Hospital) tested HIV positive and 11 of these women
agreed to take part in the study in addition to 11 women who had tested
negative. Each woman took part in an in-depth interview and were asked:
“Did you ever feel that you were being ‘pressured’ or ‘forced’ into taking the
test when you were pregnant?” “Did you ask for an HIV test?” and “Did you
ever suspect or have reason to believe that you might be positive?” Some
example questions for HIV positive women only were: “Did you ever
consider terminating your pregnancy?” “Did you accept antiretroviral
treatment during your pregnancy?” “Have you lost friends when they learned
that you have HIV infection? Did your having a positive HIV test lead to
others getting tested?” “What is your opinion of the Connecticut law that says
that if you do not get an HIV test when you are pregnant, that your baby will
be tested?” and “Do you wish there was no such law?” (Simpson & Forsyth
2007).
Some of the most important data to come out of this study was that of
the women who tested HIV positive, 7 out of 11 said that if they had not lived
in Connecticut where the test was mandatory they would not have been tested
at all. Also, of the 11 HIV positive women 9 said that they were “stunned” to
find out that they were HIV positive. This shows that the law in effect is doing
exactly what it was designed for: to identify the HIV positive pregnant women
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who would have otherwise fallen through the cracks, either because they did
not want to take the test or they felt they had no reason to take it. All 11 HIV
positive women, after hearing their diagnosis started antiretroviral therapy and
all 12 children (including one set of twins) ended up being HIV negative at 6
months of age (Simpson & Forsyth 2007).
Many of the women expressed feelings such as guilt, shame, sadness,
denial, isolation and loss of hope, in other words feelings that are considered
common for someone receiving a life-threatening diagnosis. In regards to the
women’s feelings about the Connecticut law, they were for the most part very
positive. Responses included: “I’m so glad; my baby would have been
infected. How can you deny it?” “I’m glad we have this law.” “I’m just glad I
got pregnant because I got to know about my HIV.” Women also stated that
they thought the law was: “beneficial,” and “common sense,” and that the law
should be “tougher,” and “stronger.” Only two women who tested positive
believed that their lives had been affected in a negative way by having to take
an HIV test.
Overall, what this study shows is that, in general, even among women
who at first do not want to take an HIV test, upon learning their status, they
were grateful that the law was in place, for both their own health and their
baby’s. Also, this study shows that laws such as the one in place in
Connecticut have the potential to diagnosis and treat women who otherwise
would not have be tested.

Discussion
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Although there are strong arguments against making HIV testing
during pregnancy mandatory, ultimately I believe that prenatal mandatory
testing has many potential benefits that outweigh the potential risks, the
largest being that both the mother and child can receive treatment. Yet it is
important to note that mandatory testing cannot be implemented without
certain conditions being met. First and foremost, pre and post-test counseling
must still be in place. It is imperative that the women understand what an HIV
test entails and what an HIV positive test result means for herself and her
baby. If necessary, health care providers should be able to refer women to
counseling, just as they would for any other patient receiving life changing
news. Secondly, the mother must have the right to and access to an abortion.
If a woman feels that even with the treatment options available to prevent
vertical transmission of HIV, she does not wish to take such a risk, she must
have the option to terminate the pregnancy, if the test has occurred within the
legal time frame in which termination is possible. Another condition that must
be met is that of treatment. Both the woman and her baby must have access to
antiretroviral treatment. If for any reason, whether financial or other reasons,
the woman does not have access to such treatment, for at least the period of
her pregnancy, then it would be unethical to force a fatal diagnosis upon her
and her infant if said knowledge was not desired by the woman. Finally, and
possibly most importantly is the matter of confidentiality. Confidentiality
must be maintained. I believe that women would are wary of mandatory HIV
testing and would therefore be deterred from prenatal care would feel more
comfortable and confident in having a law that mandated an HIV test during
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pregnancy if they were assured that their HIV status was to be kept
confidential (Schuklenk & Kleinsmidt 2007). Further, if for any reason, one or
more of these conditions are not able to be met, I find that the next option for
testing should be opt-out testing for pregnant women and mandatory HIV
screenings for newborns.
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Conclusion
HIV testing would not be the first test to be made mandatory for pregnant
women. When a woman goes in for prenatal care, she and her baby go through
a battery of tests including but not limited to the Rh antigen, phenylketonuria
(PKU) and syphilis. All of these diseases have the potential to be passed on to
the newborn and dramatically affect the quality of life of the baby. It is for this
reason that these tests have become routine for every women. For the most
part many mandatory tests over the years have become routine. They are
something that every woman receives without questions and without the need
to get written or even verbal consent, other than her written consent for her
prenatal care. That is the hope that the CDC had when they revised the
recommendations to opt-out testing for HIV. Every test needs to start
somewhere on its way to becoming routine and for HIV I believe that
mandatory testing is the best place to begin.
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Summary
Today in America one of the largest social issues that we struggle
with is distinguishing whose rights should ethically, morally and legally
come first, that of the woman or that of the fetus. While most people only
think of this argument in the terms of abortion rights, in this paper I will
be looking at the issue from the standpoint of preventing the further
spread of HIV. Currently in the United States if a pregnant woman is HIV
positive and does not receive treatment for the disease, her newborn has
a 35% chance of being born HIV positive. Luckily there is treatment that if
done throughout the pregnancy that reduces risk to less a than 2%
chance of contracting HIV. Yet, one of the biggest barriers preventing the
total elimination of mother-to-child transmission of HIV is that some
women are unaware of their HIV status during pregnancy and therefore
these precautions are not always taken. The question that I address in my
thesis is whether or not state governments should go so far as to make
HIV testing during pregnancy a routine and mandatory issue. I believe
that the answer is yes, but what are the ramifications and the legal
precedent in doing so?
In any such ethical dilemma, it is important to look at both sides of
the argument. In the case of mandatory HIV testing during pregnancy, the
main concerns for the group against it are stigma and discrimination
related to or caused by taking an HIV test and the loss of autonomy or the
right to make their own medical decisions and have them respected by a
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health care provider. Other concerns include how the law or protocol
would be enforced if a woman does not wish to have an HIV test and that
mandatory HIV testing may deter women who already distrust the health
system from seeking any prenatal care, not just HIV testing.
On the other hand the arguments used my proponents for
mandatory HIV testing during pregnancy include that the health benefits
of HIV testing during pregnancy outweigh the harm that is created by
stigma and discrimination. For example, the ability of the women to start
antiretroviral therapy is beneficial not only for herself but also for her
baby. Eradicating mother-to-child transmission (PMTCT) in the United
States is a very realistic goal. Another argument that once a woman has
committed to carry her baby to term, or has reached the age of viability
for the fetus (23 weeks), she has gained the responsibility to prevent any
unnecessary harm to the child. This includes doing all that is possible to
prevent the vertical transmission of HIV. Other arguments used by the
pro mandatory testing front include the cost effectiveness of prevention
in comparison to the life-long treatment of an HIV infected infant, as well
as a possible reduction of stigma as a result of making an HIV test
something that every woman takes as part her prenatal care.
In this paper I look also look at case studies and precedents for
mandatory testing of HIV during pregnancy. One such example is an indepth look at a study done at the Yale New Haven Hospital in Connecticut
in order to evaluate the personal feelings of pregnant women of the law
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that was enacted in 1999. I also look at cases such as syphilis testing
during pregnancy and the impact that the abortion debate in the United
States has on this issue.
As you may be able to see, the issue of mandatory HIV testing
during pregnancy is fraught with turbulence. Yet it is an important issue
to discuss because it has the potential to reduce the number of infants
born each year with a fatal disease. Although this paper is mainly
concerned with mandatory HIV testing during pregnancy in the United
States, I hope that other countries where mother-to-child transmission of
HIV is much more significant would able to look at this paper and see that
mandatory HIV testing has the potential to lower not only the vertical
transmission of HIV in their country but also their infant mortality rates. I
believe that mandatory HIV testing during pregnancy has many benefits
that outweigh any downsides, the main one being that both the mother
and child may have the ability to live longer and healthier lives.

